Loading...

Meghan Morris, PhD, MPH

Title(s)Assistant Professor, Epidemiology & Biostatistics
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-574-0651
EmailMeghan.Morris@ucsf.edu
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco, CA2019Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    University of California, San Francisco2015  - 2018John A. Watson Faculty Award
    University of California, San Francisco2012  - 2013CFAR Development Award for Research
    University of California, San Franicsco2012  - 2013Center for AIDS Research (CFAR) Andy I. Choi Mentoring Program
    NIH/NIDA2011Women & Sex/Gender Junior Investigator Award
    San Diego State University2010President's Award for Scholarly Research
    San Diego State University2006  - 2008BIXBY Scholarship in Population Research

    Collapse Overview 
    Collapse Overview
    My professional activities are grounded in engaging diverse partners in the development of evidence-based policy change to reduce social inequalities and improve health among underserved communities.

    As an Assistant Professor, my research focuses on applying epidemiological methods to study the impact of individual, social, and structural factors on disease transmission within marginalized populations. In particular, my work has focused on using qualitative and quantitative methods to examine social determinants of health within persons who use drugs, including HIV and hepatitis C virus (HCV) infection, worldwide. Internationally I have collaborated with researchers to carry out HIV and HCV prevention studies in the U.S.-Mexico border region, Jamaica, Australia, Tanzania, and Namibia. Through a recently awarded NIH/NIDA K01 study my work focuses on the collection and analysis of dyadic data (data collected from both members of a pair) to examine the influence of interpersonal factors on disease transmission. Recently I have expanded my research to include the intersection of criminal justice systems and health among people who use drugs.

    As an educator, I take pleasure in exposing learners to the intersection of social justice and epidemiology. I addition to formal teaching, including EPI253: Infectious Disease Epidemiology, I provide mentorship to a diverse set of learners from the fields of sociology, medicine, nursing, and public health.

    Prior to joining UCSF as a Postdoctoral Research Fellow in infectious disease epidemiology, I received a Bachelor’s of Science degree in Biochemistry & Cellular Biology from University of California, San Diego (UCSD), a MPH in epidemiology from San Diego State University (SDSU), and PhD in Global Health with concentration in Epidemiology from UCSD/SDSU’s Joint Doctoral Program in Public Health.

    Collapse Research 
    Collapse Research Activities and Funding
    Assessing COVID-19 knowledge and COVID-19 impact on food insecurity, housing stability, isolation, and experiences of stigmatization for people who use drugs and low-income San Franciscans
    UCSF COVID-19 Related Rapid Research Pilot Initiative Jun 3, 2020 - Jun 2, 2021
    Role: Principle Investigator
    The No One Waits (NOW) Study: Acceptability, Feasibility, and Effectiveness of a Community On-Site Point-of-Diagnosis HCV Treatment Study
    Gilead Sciences IN-US-342-5516Sep 1, 2019 - Aug 31, 2021
    Role: Principle Investigator
    Role Description: The proposed study will evaluate the feasibility and acceptability of an accelerated treatment program started at time of chronic HCV diagnosis (intervention) (n=150), and effectiveness assessed by the proportion attaining SVR12 and completing a full course of HCV treatment. Findings from the proposed study will directly inform the scale-up of similar point-of-diagnosis treatment programs at community-based HCV screening sites. Moreover, this study will lay the necessary groundwork to incorporate future point-of-care one-step testing, including rapid fingerstick HCV RNA testing once FDA approved, into a true test-and-treat model.
    Informing hepatitis C virus elimination strategies with epidemiological data from highest need populations
    NIH/NIDA R21DA046809Jul 15, 2019 - Jun 30, 2021
    Role: Principal Investigator
    Role Description: This 2-year project will generate new estimates of hepatitis C virus (HCV) screening and treatment outcomes for underserved, but high-risk groups (young people who inject drugs, men who have sex with men and inject drugs, and transgender women) to identify subgroup specific policy/programmatic interventions.
    Understanding the interpersonal context of HIV/HCV risk within injecting dyads
    NIH/NIDA K01DA037802Aug 1, 2014 - Jul 31, 2019
    Role: Principal Investigator
    Role Description: This 5-year renewal supports extends a well established observational cohort of young adult injection drug users, studying factors that will inform and translate to the prevention of HIV and HCV.

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health
    Collapse Websites
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The Society for Epidemiologic Research (SER) and the Future of Diversity and Inclusion in Epidemiology1. Am J Epidemiol. 2020 Jun 30. Gilman SE, Arah OA, Bates L, Branas CC, Cozier YC, Datta GD, DeVilbiss EA, Fink DS, Hajat A, Johnson DA, Lopez DS, Morris MD, Weuve J, Abuelezam NN. PMID: 32602528.
      View in: PubMed   Mentions:    Fields:    
    2. Assessing Representation and Perceived Inclusion among Members in the Society for Epidemiologic Research. Am J Epidemiol. 2020 Jan 07. DeVilbiss EA, Weuve J, Fink DS, Morris MD, Arah OA, Radoc JG, Datta GD, Abuelezam NN, Lopez DS, Johnson DA, Branas CC, Schisterman EF. PMID: 31907518.
      View in: PubMed   Mentions: 1     Fields:    
    3. Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection. Clin Infect Dis. 2020 01 01; 70(1):123-131. Geddes L, Iversen J, Wand H, Esmaeili A, Tsui J, Hellard M, Dore G, Grebely J, Dietze P, Bruneau J, Prins M, Morris MD, Shoukry NH, Lloyd AR, Kim AY, Lauer G, Cox AL, Page K, Maher L. PMID: 30816419.
      View in: PubMed   Mentions: 1     Fields:    
    4. HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco. PLoS One. 2019; 14(12):e0226166. Page K, Evans JL, Hahn JA, Vickerman P, Shiboski S, Morris MD. PMID: 31821365.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco. PLoS ONE. 2019 Dec 10; 14(12):e0226166. Kimberly Page, Jennifer L. Evans, Judith A. Hahn, Peter Vickerman, Stephen Shiboski, Meghan D. Morris. .
      View in: Publisher Site   Mentions:
    6. Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran. AIDS Behav. 2019 Jun; 23(6):1594-1603. Esmaeili A, Shokoohi M, Danesh A, Sharifi H, Karamouzian M, Haghdoost A, Shahesmaeili A, Akbarpour S, Morris MD, Mirzazadeh A. PMID: 30460664.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    7. Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships. PLoS One. 2019; 14(5):e0217811. Morris MD, Andrew E, Tan JY, Maher L, Hoff C, Darbes L, Page K. PMID: 31150518.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships. Open Forum Infect Dis. 2019 Apr; 6(4):ofz125. Hahn JA, Tully DC, Evans JL, Morris MD, Briceno A, Bean DJ, Allen TM, Page K. PMID: 31041340.
      View in: PubMed   Mentions:
    9. Effects of a voter initiative on disparities in punishment severity for drug offenses across California counties. Soc Sci Med. 2019 06; 230:9-19. Mooney AC, Neilands TB, Giannella E, Morris MD, Tulsky J, Glymour MM. PMID: 30947103.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated. Drug Alcohol Depend. 2019 05 01; 198:133-135. Morris MD, Mirzazadeh A, Evans JL, Briceno A, Coffin P, Hahn JA, Page KA. PMID: 30921649.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination. PLoS One. 2018; 13(7):e0200866. Facente SN, Grebe E, Burk K, Morris MD, Murphy EL, Mirzazadeh A, Smith AA, Sanchez MA, Evans JL, Nishimura A, Raymond HF. PMID: 30001389.
      View in: PubMed   Mentions:    Fields:    
    12. Illicit Drug Users in the Tanzanian Hinterland: Population Size Estimation Through Key Informant-Driven Hot Spot Mapping. AIDS Behav. 2018 Jul; 22(Suppl 1):4-9. Ndayongeje J, Msami A, Laurent YI, Mwankemwa S, Makumbuli M, Ngonyani AM, Tiberio J, Welty S, Said C, Morris MD, McFarland W. PMID: 29435795.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    13. Racial/Ethnic Disparities in Arrests for Drug Possession After California Proposition 47, 2011-2016. Am J Public Health. 2018 08; 108(8):987-993. Mooney AC, Giannella E, Glymour MM, Neilands TB, Morris MD, Tulsky J, Sudhinaraset M. PMID: 29927653.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination. PLoS One. 2018; 13(4):e0195575. Facente SN, Grebe E, Burk K, Morris MD, Murphy EL, Mirzazadeh A, Smith AA, Sanchez MA, Evans JL, Nishimura A, Raymond HF. PMID: 29641546.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative. Clin Infect Dis. 2018 01 06; 66(1):20-28. Esmaeili A, Mirzazadeh A, Morris MD, Hajarizadeh B, Sacks HS, Maher L, Grebely J, Kim AY, Lauer G, Cox AL, Hellard M, Dietze P, Bruneau J, Shoukry NH, Dore GJ, Lloyd AR, Prins M, Page K. PMID: 29020200.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. A Study of Sexual Relationship Power among Young Women Who Inject Drugs and Their Sexual Partners. Subst Use Misuse. 2018 07 03; 53(8):1281-1287. Morris MD, Montgomery ME, Briceno A, Evans JL, Andrew EVW, Page K, Hahn JA. PMID: 29286888.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Context and characteristics of illicit drug use in coastal and interior Tanzania. Int J Drug Policy. 2018 01; 51:20-26. Tiberio J, Laurent YI, Ndayongeje J, Msami A, Welty S, Ngonyani A, Mwankemwa S, Makumbuli M, McFarland W, Morris MD. PMID: 29156310.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health. Int J Prison Health. 2017 09 11; 13(3-4):192-199. Morris MD, Brown B, Allen SA. PMID: 28914118.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    19. Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships. Int J Drug Policy. 2017 10; 48:54-62. Morris MD, Neilands TB, Andrew E, Maher L, Page KA, Hahn JA. PMID: 28804051.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration. Clin Infect Dis. 2017 Apr 01; 64(7):860-869. Morris MD, Shiboski S, Bruneau J, Hahn JA, Hellard M, Prins M, Cox AL, Dore G, Grebely J, Kim AY, Lauer GM, Lloyd A, Rice T, Shoukry N, Maher L, Page K. PMID: 28362947.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsPHPublic Health
    21. Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection. Infect Genet Evol. 2017 04; 49:88-96. Rodrigo C, Walker MR, Leung P, Eltahla AA, Grebely J, Dore GJ, Applegate T, Page K, Dwivedi S, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Luciani F, Lloyd AR, Bull RA. PMID: 28065804.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    22. Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia. J Infect Dis. 2016 Nov 01; 214(9):1383-1389. Rodrigo C, Eltahla AA, Bull RA, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Estes C, Razavi H, Lloyd AR, Luciani F. PMID: 27571901.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    23. Population-based risks of mortality and preterm morbidity by gestational age and birth weight. J Perinatol. 2016 11; 36(11):1008-1013. Baer RJ, Rogers EE, Partridge JC, Anderson JG, Morris M, Kuppermann M, Franck LS, Rand L, Jelliffe-Pawlowski LL. PMID: 27467566.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative. Open Forum Infect Dis. 2016 Jan; 3(1):ofw024. Page K, Mirzazadeh A, Rice TM, Grebely J, Kim AY, Cox AL, Morris MD, Hellard M, Bruneau J, Shoukry NH, Dore GJ, Maher L, Lloyd AR, Lauer G, Prins M, McGovern BH. PMID: 26973850.
      View in: PubMed   Mentions:
    25. More than just someone to inject drugs with: Injecting within primary injection partnerships. Drug Alcohol Depend. 2015 Nov 01; 156:275-281. Morris MD, Bates A, Andrew E, Hahn J, Page K, Maher L. PMID: 26460140.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    26. Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort. J Viral Hepat. 2015 Dec; 22(12):1020-32. Doyle JS, Deterding K, Grebely J, Wedemeyer H, Sacks-Davis R, Spelman T, Matthews G, Rice TM, Morris MD, McGovern BH, Kim AY, Bruneau J, Lloyd AR, Page K, Manns MP, Hellard ME, Dore GJ. PMID: 26098993.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    27. Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study. J Infect Dis. 2015 Nov 01; 212(9):1407-19. Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris M, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M. PMID: 25883387.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    28. Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study. PLoS One. 2015; 10(4):e0122232. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Dore GJ, Grebely J. PMID: 25837807.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    29. A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs. J Epidemiol Community Health. 2015 Aug; 69(8):745-52. Spelman T, Morris MD, Zang G, Rice T, Page K, Maher L, Lloyd A, Grebely J, Dore GJ, Kim AY, Shoukry NH, Hellard M, Bruneau J. PMID: 25814695.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    30. Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA. PLoS One. 2014; 9(10):e109282. Morris MD, Evans J, Montgomery M, Yu M, Briceno A, Page K, Hahn JA. PMID: 25286346.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    31. Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study. J Clin Virol. 2014 Nov; 61(3):430-4. Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J. PMID: 25256151.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    32. Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA. Drug Alcohol Depend. 2014 Sep 01; 142:239-44. Evans JL, Morris MD, Yu M, Page K, Hahn JA. PMID: 25034898.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort. BMJ Open. 2014 May 29; 4(5):e004988. Tracy D, Hahn JA, Fuller Lewis C, Evans J, Briceño A, Morris MD, Lum PJ, Page K. PMID: 24875490.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    34. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014 Jan; 59(1):109-20. Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY, McGovern BH, Schinkel J, George J, Shoukry NH, Lauer GM, Maher L, Lloyd AR, Hellard M, Dore GJ, Prins M. PMID: 23908124.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansCells
    35. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. Clin Infect Dis. 2013 Aug; 57 Suppl 2:S32-8. Page K, Morris MD, Hahn JA, Maher L, Prins M. PMID: 23884063.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansPHPublic Health
    36. Characteristics and health service utilization in two samples of young injection drug users recruited using direct and referral methods in San Francisco, California. J Alcohol Drug Depend. 2013 Aug; 1(5). Briceño A, Morris MD, Evans J, Raymond HF, Page K. PMID: 26236757.
      View in: PubMed   Mentions:
    37. Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient's perspective. Int J Tuberc Lung Dis. 2013 Jul; 17(7):954-60. Morris MD, Quezada L, Bhat P, Moser K, Smith J, Perez H, Laniado-Laborin R, Estrada-Guzman J, Rodwell TC. PMID: 23743315.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    38. 1157 EARLY HCVRNA DYNAMICS AND FACTORS ASSOCIATED WITH HIGH EARLY HCVRNA LEVEL DURING ACUTE HCV INFECTION. Journal of Hepatology. 2013 Apr 1; 58:s470-s471. B. Hajarizadeh, K. Page, A.Y. Kim, B.H. McGovern, A.L. Cox, T.M. Rice, R. Sacks-Davis, J. Bruneau, M. Morris, J. Amin, B. Grady, J. Schinkel, L. Maher, M. Hellard, A.R. Lloyd, M. Prins, J. Grebely, G.J. Dore, on behalf of the InC Study Group. .
      View in: Publisher Site   Mentions:
    39. Characteristics and Health Service Utilization in Two Samples of Young Injection Drug Users Recruited Using Direct and Referral Methods in San Francisco, California. Alcoholism & Drug Dependence. 2013; 1(5). Briceno A, Morris M.D., Evans J, Fisher R.H., and Page K, .View Publication.
    40. Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study. Int J Epidemiol. 2013 Dec; 42(6):1649-59. Grebely J, Morris MD, Rice TM, Bruneau J, Cox AL, Kim AY, McGovern BH, Shoukry NH, Lauer G, Maher L, Lloyd AR, Hellard M, Prins M, Dore GJ, Page K. PMID: 23203695.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    41. Factors associated with pathways toward concurrent sex work and injection drug use among female sex workers who inject drugs in northern Mexico. Addiction. 2013 Jan; 108(1):161-70. Morris MD, Lemus H, Wagner KD, Martinez G, Lozada R, Gómez RM, Strathdee SA. PMID: 22775475.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    42. Prevalence and correlates of female condom use and interest among injection drug-using female sex workers in two Mexico-US border cities. AIDS Behav. 2012 Oct; 16(7):1877-86. Stockman JK, Morris MD, Martinez G, Lozada R, Patterson TL, Ulibarri MD, Vera A, Strathdee SA. PMID: 22711225.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    43. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis. 2012 May; 12(5):408-14. Grebely J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, Page K, Lloyd AR, Dore GJ. PMID: 22541630.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    44. "Injection first": a unique group of injection drug users in Tijuana, Mexico. Am J Addict. 2012 Jan-Feb; 21(1):23-30. Morris MD, Brouwer KC, Lozada RM, Gallardo M, Vera A, Strathdee SA. PMID: 22211343.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    45. Prevalence and correlates of 'agua celeste' use among female sex workers who inject drugs in Ciudad Juarez, Mexico. Drug Alcohol Depend. 2011 Sep 01; 117(2-3):219-25. Morris MD, Case P, Robertson AM, Lozada R, Vera A, Clapp JD, Medina-Mora ME, Strathdee SA. PMID: 21441001.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. Under- and over-nutrition among refugees in San Diego County, California. J Immigr Minor Health. 2011 Feb; 13(1):161-8. Rondinelli AJ, Morris MD, Rodwell TC, Moser KS, Paida P, Popper ST, Brouwer KC. PMID: 20505992.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    47. Healthcare barriers of refugees post-resettlement. J Community Health. 2009 Dec; 34(6):529-38. Morris MD, Popper ST, Rodwell TC, Brodine SK, Brouwer KC. PMID: 19705264.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    Meghan's Networks
    Concepts (171)
    Derived automatically from this person's publications.
    _
    Co-Authors (23)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _